Invention Grant
- Patent Title: Iniparib formulations and uses thereof
-
Application No.: US16652387Application Date: 2018-09-28
-
Publication No.: US11628144B2Publication Date: 2023-04-18
- Inventor: Thomas F. White , Stephen M. Nava
- Applicant: TriAct Therapeutics, Inc.
- Applicant Address: US CA San Francisco
- Assignee: TriAct Therapeutics, Inc.
- Current Assignee: TriAct Therapeutics, Inc.
- Current Assignee Address: US CA San Francisco
- Agency: Wilson Sonsini Goodrich & Rosati
- International Application: PCT/US2018/053558 WO 20180928
- International Announcement: WO2019/067991 WO 20190404
- Main IPC: A61K9/28
- IPC: A61K9/28 ; A61K9/00 ; A61K9/08 ; A61K9/20 ; A61K9/48 ; A61K31/166 ; A61K47/10 ; A61K47/12 ; A61K47/14 ; A61K47/20 ; A61K47/32 ; A61K47/34 ; A61K47/38 ; A61K31/495
Abstract:
Disclosed herein are pharmaceutical compositions, formulations, and dosage forms and their use in the treatment of a cancer. Also disclosed herein are methods of treating a cancer in a subject in need thereof.
Public/Granted literature
- US20200297644A1 INIPARIB FORMULATIONS AND USES THEREOF Public/Granted day:2020-09-24
Information query
